Parotid gland carcinoma ex pleomorphic adenoma

Summary

Parotid gland carcinoma ex pleomorphic adenoma (MONDO:0006357) is a cancer. A subtype of major salivary gland carcinoma ex pleomorphic adenoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	parotid gland carcinoma ex pleomorphic adenoma
Mondo ID	MONDO:0006357
EFO	EFO:1000461
NCIT	C5974
SNOMED CT	425127006
UMLS	C1335356
MedGen	233311
GARD	0027750
Anatomy (UBERON)	UBERON:0001831
Is cancer (heuristic)	yes

Also known as: carcinoma ex pleomorphic adenoma of parotid · carcinoma ex pleomorphic adenoma of parotid gland · carcinoma ex pleomorphic adenoma of the parotid · carcinoma ex pleomorphic adenoma of the parotid gland · parotid carcinoma ex pleomorphic adenoma · parotid gland carcinoma ex pleomorphic adenoma

Disease family

This is a subtype of major salivary gland carcinoma ex pleomorphic adenoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › digestive system disorder › digestive system cancer › oral cavity cancer › salivary gland cancer › salivary gland carcinoma › major salivary gland carcinoma › major salivary gland carcinoma ex pleomorphic adenoma › parotid gland carcinoma ex pleomorphic adenoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.